Applications are still being accepted for 2025 LUNGevity Research Award Programs. A brief description of each award program is below. More detailed information about these awards, submission deadlines, and instructions on how to apply can be found at www.lungevity.org/RFAs. Please contact Jody Roosevelt at jroosevelt@LUNGevity.org with any questions.
We hope that you will share this information with those in your organization who might be interested in applying.
New in 2025! Mid-Career “Bridge to Breathe” Award: This program will support established mid-career investigators who are seeking bridge funding to sustain their lung cancer research program while they resubmit their application for federal funding (NIH R01) or its equivalent. Mid-career investigators are often burdened by increasing administrative demands that jeopardize their ability to conduct cutting-edge research that will generate the new treatments and potential cures of tomorrow. This new mechanism is part of LUNGevity’s ongoing commitment to workforce development and is intended to maintain a robust pipeline of thoracic oncology leaders and research. This is a $150,000 two-year award. Letters of Intent for this award are due February 14.
New in 2025! Rising Tide Foundation for Clinical Cancer Research and LUNGevity Foundation for Early Detection Research Awards in Lung Cancer: This award mechanism will support innovative studies in the early detection of lung cancer. The award will support clinical trials and validation studies that use new imaging, blood biomarkers, or monitoring algorithms and involve patient partners in the study design and execution. Investigators may receive up to $1,000,000 per award, over three years. Letters of Intent for this award are due February 12.
ASTRO-LUNGevity Residents/Fellows in Radiation Oncology Seed Grant: This program will foster and develop the research careers of residents and fellows interested in radiation oncology-related basic, translational and/or clinical research to benefit patients with lung cancer. This is a $50,000 one-year award. Applications for this award are due March 10.
Career Development Award: This program supports future research leaders who will keep the field of lung cancer research vibrant with new ideas. Funded projects are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy. This is a $300,000 three-year award. Letters of Intent for this award are due February 14.
Health Equity and Inclusiveness Research Fellow Award: This program supports fellows who belong to underrepresented minorities in STEM who are interested in lung cancer research. Applicants must hold a doctoral degree, be pursuing a postdoctoral fellowship, and plan to pursue a career in lung cancer. This is a $100,000 two-year award. Letters of Intent for this award are due February 14.
VA Research Scholar Award: This program supports investigators interested in lung cancer research within the VA System. Applicants must hold a doctoral degree and either be pursuing a postdoctoral fellowship program or be junior faculty within the first five years of their faculty appointment at the time of application. This is a $100,000 two-year award. Letters of Intent for this award are due February 14.
